Form 4 for EDIT Editas Medicine, Inc.
Accepted 2022-12-06 00:00:00 ET · period of report 2022-12-05 · accession 0001415889-22-012132 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-06 | 2022-12-05 | EDIT | ROBERTSON MICHELLE | EVP, CFO | S - Sale | $10.23 | -193 | 82.3K | -0.2% | -$1,974 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-05 | S | D | 193 | $10.23 | 82,282 | D | — | — |